Filing Details
- Accession Number:
- 0001179110-14-009419
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-30 17:51:57
- Reporting Period:
- 2014-05-29
- Filing Date:
- 2014-05-30
- Accepted Time:
- 2014-05-30 17:51:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1360886 | Osiris Therapeutics Inc. | OSIR | Biological Products, (No Disgnostic Substances) (2836) | 710881115 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1476315 | Paul Matthew Neumayer | Osiris Therapeutics, Inc. 7015 Albert Einstein Drive Columbia MD 21046 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-05-29 | 500 | $6.46 | 500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-05-29 | 500 | $15.55 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Incentive Stock Options, right to buy | Disposition | 2014-05-29 | 500 | $6.46 | 500 | $6.46 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,375 | 2014-05-27 | 2020-05-27 | No | 4 | M | Direct |
Footnotes
- Represents incentive stock options to purchase common stock with the stated expiration date